GRI · GRI Bio, Inc. · Executive Compensation
$1.90
-0.06 (-3.06%)
At close · Oct 5
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, there is substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$4.48M
Shares
2.19M
Volume · Oct 5
84.6K
Avg daily vol (3M)
328.87K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Leanne Kelly | Chief Financial Officer | $584,722 |
| Vipin Kumar | Chief Scientific Officer | $579,087 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Leanne M. Kelly | Chief Financial Officer | $469,420 |
| Leanne Kelly | Chief Financial Officer | $469,420 |
| Vipin Kumar | Chief Scientific Officer | $419,420 |
| Vipin Kumar Chaturvedi | Chief Scientific Officer | $419,420 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| David Baker | Former President and Chief Executive Officer | $1,297,051 |
| W. Marc Hertz | President and Chief Executive Officer | $785,764 |
| Leanne Kelly | Chief Financial Officer | $646,617 |
| Leanne M. Kelly | Chief Financial Officer | $646,617 |
| Albert Agro | Chief Medical Officer | $406,986 |
| Vipin Kumar Chaturvedi | Chief Scientific Officer | $302,853 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| David Baker | Former President and Chief Executive Officer | $919,564 |
| Leanne Kelly | Chief Financial Officer | $673,541 |
| Leanne M. Kelly | Chief Financial Officer | $673,541 |
| Penny S. Toren | Former Senior Vice President, Regulatory Affairs & Program Management | $298,337 |
| Albert Agro | Chief Medical Officer | — |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| David Baker | Former President and Chief Executive Officer | $826,880 |
| Leanne M. Kelly | Chief Financial Officer | $498,859 |
| Leanne Kelly | Chief Financial Officer | $498,859 |
| Penny S. Toren | Former Senior Vice President, Regulatory Affairs & Program Management | $359,373 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| David Baker | President and Chief Executive Officer | $669,149 |
| Penny S. Toren | Former Senior Vice President, Regulatory Affairs & Program Management | $358,199 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Camilla V. Simpson, M.Sc | Class II director | Appointed | 2025-08-13 |
| Roelof Rongen | Class II director | Appointed | 2025-08-13 |
| David Baker | President and Chief Executive Officer | Resigned | 2023-04-21 |
| Camilla V. Simpson, M.Sc. | Director | Appointed | 2023-04-21 |
| David Szekeres | Chairperson of the Board | Appointed | 2023-04-21 |
| Roelof Rongen | Director | Appointed | 2023-04-21 |
| W. Marc Hertz, Ph.D. | Director | Appointed | 2023-04-21 |
| David Szekeres | Director | Appointed | 2023-04-21 |
| Albert Agro, Ph.D. | Chief Medical Officer | Appointed | 2023-04-21 |
| Vipin Kumar Chaturvedi, Ph.D. | Chief Scientific Officer | Appointed | 2023-04-21 |
| Leanne Kelly | Chief Financial Officer (principal financial and accounting officer) | Appointed | 2023-04-21 |
| W. Marc Hertz, Ph.D. | Chief Executive Officer (principal executive officer) | Appointed | 2023-04-21 |